{"id":85,"date":"2016-08-12T19:11:19","date_gmt":"2009-08-12T19:11:19","guid":{"rendered":"http:\/\/edrugstore.uat.com\/blog\/?p=85"},"modified":"2013-07-10T21:53:02","modified_gmt":"2013-07-10T21:53:02","slug":"prilosec-and-nexium-don-t-increase-your-risk-of-heart-attacks","status":"publish","type":"post","link":"https:\/\/www.edrugstore.com\/blog\/acid-reflux\/prilosec-and-nexium-don-t-increase-your-risk-of-heart-attacks\/","title":{"rendered":"Prilosec and Nexium Don\u2019t Increase Your Risk of Heart Attacks"},"content":{"rendered":"
\"Olive
Acid Reflux medication not shown to increase risk of heart problems.<\/figcaption><\/figure>\n

The FDA has issued its conclusions regarding two small long-term clinical studies of patients with severe GERD. In these studies, patients were chosen to either receive treatment with medication (omeprazole [Prilosec] or esomeprazole [Nexium]), or to have surgery to control their gastroesophageal reflux disease.<\/p>\n

While early results from the study raised concerns that long-term use of Prilosec or Nexium may have increased the risk of heart attacks, heart failure, and heart-related sudden death in those patients taking either one of the drugs compared to patients who received surgery. <\/p>\n

The FDA’s preliminary conclusion is that this data does not suggest an increased risk of heart problems.\n<\/p>\n

While the initial data from this study suggested a difference between treatments in the rate of cardiovascular events, an updated report found that the number of patients who experienced heart problems was similar in both treatment groups.<\/p>\n

While both of these studies collected safety data, the study protocols did not specify how heart problems, such as heart attacks, were to be defined or documented. As a result, evaluating the information that has been gathered about the safety of either drug in these studies is difficult.<\/p>\n

The FDA’s conclusions are further supported by an additional analysis of 14 comparative studies of omeprazole, of which four were placebo-controlled. In these studies, there were fewer heart attacks or other heart problems reported in the patients treated with omeprazole compared to patients that were given a placebo.<\/p>\n","protected":false},"excerpt":{"rendered":"

The FDA has issued its conclusions regarding two small long-term clinical studies of patients with severe GERD. In these studies, patients were chosen to either receive treatment with medication (omeprazole [Prilosec] or esomeprazole [Nexium]), or to have surgery to control their gastroesophageal reflux disease. While early results from the study raised concerns that long-term use […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_autoblog_aioseo_focus_keyphrase":"","_autoblog_aioseo_title":"","_autoblog_aioseo_description":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-85","post","type-post","status-publish","format-standard","hentry","category-acid-reflux"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t